Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Acebutolol impurity 5 is a known impurity associated with the pharmaceutical compound Acebutolol. This reagent can be utilized in the assessment of drug purity and stability, contributing to quality control and regulatory compliance in pharmaceutical development. Its role in analytical chemistry makes it essential for researchers focused on drug formulation and safety. -
Drug Impurity
Duloxetine impurity 11 is a chemical impurity associated with Duloxetine, a serotonin-norepinephrine reuptake inhibitor. This impurity can be relevant for assessing the quality and purity of pharmaceutical formulations containing Duloxetine. Research applications include analytical chemistry, pharmaceutical development, and stability testing to ensure compliance with regulatory standards. -
Drug Impurity
Apster Impurity 51 is a chemical impurity associated with pharmaceutical formulations. It serves as an important reference standard for analytical methods related to drug quality and safety. The compound is utilized in research applications focused on impurity profiling, stability testing, and compliance with regulatory guidelines for drug development. -
Drug Intermediate
(Z)-5-(4-Iodobenzylidene)-2-thioxothiazolidin-4-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound exhibits structural characteristics that facilitate various chemical reactions, making it valuable in medicinal chemistry research. Its applications extend to the development of novel therapeutic agents with potential biological activity. -
Drug Impurity
Sorafenib impurity 2 is a chemical impurity of the multikinase inhibitor Sorafenib. This impurity can be utilized for the qualitative analysis and characterization of Sorafenib formulations in pharmaceutical research. Its presence must be monitored to ensure the purity and efficacy of drug products in development and to assess their safety profiles in biological applications. -
Pyridoxine cyclic ether Impurity
6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol hydrochloride serves as a pyridoxine cyclic ether impurity. This compound is primarily utilized in chemical research focused on the characterization and analysis of pyridoxine derivatives. Its presence may impact the stability and efficacy of related compounds, making it an essential reference standard for quality control and purity assessments in pharmaceutical development. -
Drug Impurity
Sertraline impurity 14 is a chemical impurities derived from the selective serotonin reuptake inhibitor (SSRI) sertraline. This compound serves as a critical reference standard for the quality control and analysis of pharmaceutical formulations containing sertraline. Its characterization is essential for ensuring the purity and compliance of drug products, providing valuable insights into metabolite behavior and stability during research applications. -
Drug Impurity
Aripiprazole impurity 9 is identified as a pharmaceutical impurity of Aripiprazole. It serves as an important reference standard for quality control and analytical studies in drug development. This compound is essential for researchers focused on the identification and quantification of impurities in pharmaceutical formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Apixaban impurity 4 is a known impurity of the anticoagulant Apixaban, primarily utilized for assessing drug purity and quality control during pharmaceutical development. Its presence can influence pharmacological efficacy and safety assessments, making it relevant in analytical chemistry and regulatory compliance studies. This reagent aids in the detailed characterization of Apixaban formulations and contributes to the understanding of potential variations in drug composition. -
Drug Impurity
Bupropion impurity 15, chemically identified as 3-Bromophenyl Ethyl Ketone, serves as a drug impurity associated with the antidepressant Bupropion. This compound is commonly used in the assessment of pharmaceutical quality and purity standards, as well as in the study of drug metabolism and pharmacokinetics. Its analysis is crucial for ensuring the safety and efficacy of Bupropion formulations in therapeutic applications. -
Drug Impurity
Ibrutinib impurity 2 is a chemical impurity associated with the drug Ibrutinib, which targets Bruton's tyrosine kinase (BTK). As a research reagent, it can be utilized in studies investigating the purity and stability of pharmaceutical formulations, as well as in the development of analytic methods for quality control. Its presence in formulations may influence drug efficacy and safety profiles, making it relevant for ongoing pharmaceutical research. -
Drug Impurity
Sitagliptin impurity 6 is a known impurity associated with the antidiabetic medication Sitagliptin. This compound may be utilized in quality control and validation processes for the characterization of Sitagliptin formulations. Its presence and analysis are important for ensuring the safety and efficacy of pharmaceutical products containing Sitagliptin. -
Drug Impurity
Aripiprazole impurity 27 is identified as a drug impurity associated with the antipsychotic agent Aripiprazole. This compound is important for analytical and quality control studies in pharmaceutical research, as it aids in assessing the purity and stability of Aripiprazole formulations. Its characterization is essential for regulatory compliance and ensuring the safety and efficacy of related therapeutic products. -
Biochemical Assay Reagent
4-Hydroxydiphenylamine, also known as p-Anilinophenol, functions as a biochemical assay reagent. Exhibiting antioxidant properties, it is utilized as a catalyst and intermediate in various chemical reactions for the synthesis of other compounds. This compound is valuable in research applications related to environmental science and toxicology, helping to analyze and understand chemical interactions and effects. -
Drug Impurity
Dacomitinib impurity 3 is a known impurity associated with the tyrosine kinase inhibitor Dacomitinib. This compound can be utilized in analytical studies to evaluate the purity and stability of pharmaceutical formulations containing Dacomitinib. Its characterization is essential for ensuring the quality and compliance of drug products in the development process. -
Drug Impurity
Clopidogrel impurity 3 is a known impurity associated with Clopidogrel, a popular antiplatelet medication. This compound serves as an important analytical reference in the assessment of drug purity and quality control. Its characterization is essential for the evaluation of formulation stability and potential pharmacological effects during research and development. -
Drug Impurity
Ticagrelor impurity 22 is a known impurity associated with Ticagrelor, a potent P2Y12 platelet receptor inhibitor. This compound is utilized in the characterization of drug formulations and is critical for ensuring the quality and safety of pharmaceutical products. Its study is essential for regulatory compliance and may assist in understanding the stability and degradation pathways of Ticagrelor-based therapies. -
Drug Intermediate
Cyanoacetohydrazide serves as a pharmaceutical intermediate, primarily utilized in the synthesis of acylhydrazide hydrazone derivatives. These derivatives have demonstrated notable antibacterial and anti-tumor activities, making cyanoacetohydrazide a valuable compound in drug development and medicinal chemistry research. Its versatile applications in synthesizing bioactive compounds contribute significantly to advancing therapeutic strategies. -
Drug Intermediate
3-(4-Chlorophenoxy)-4-methylaniline serves as a critical drug intermediate utilized in the synthesis of a range of active pharmaceutical ingredients. This compound is integral in the development of various therapeutic agents, enabling effective chemical transformations in medicinal chemistry. Its unique structural features allow for versatile applications in pharmaceutical research and development. -
Drug Impurity
Omeprazole impurity 13 is a chemical impurity associated with the proton pump inhibitor omeprazole. It is utilized primarily in drug quality control and stability studies to ensure the purity of omeprazole formulations. The characterization of this impurity is crucial for regulatory compliance and assessing the safety and efficacy of pharmaceutical products containing omeprazole. -
Biochemical Reagent
Drotaveraldine is a biochemical reagent that participates in domino reactions with α,β-unsaturated aldehydes. Through these reactions, it enables the synthesis of pyrrolo[2,1-a]isoquinolines, which are valuable intermediates in chemical research. This compound is utilized in studies focused on organic synthesis and the development of novel biochemical pathways. -
Drug Impurity
2-Hydroxy-3-nitrobenzaldehyde is characterized as a drug impurity, primarily affecting the purity profile of pharmaceutical compounds. This compound serves as an important reference standard in analytical chemistry, utilized in the assessment of drug formulations and in quality control processes. Its presence can impact pharmacokinetics and safety evaluations, making it relevant for research focusing on drug development and regulatory compliance. -
Drug Impurity
Vitamin Impurity 2 is a known impurity associated with Vitamin compounds. It serves as a critical reference standard in pharmaceutical research and development to evaluate the purity and quality of Vitamin formulations. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Intermediate
2,3,4-Tri-O-acetyl-β-D-glucuronide methyl ester is a synthetic intermediate utilized in the preparation of prodrug forms of the antitumor antibiotic Daunomycin. This compound exhibits crucial functionalities in glycosylation reactions, facilitating drug development and optimization. Its applications in medicinal chemistry and pharmaceutical research make it a valuable reagent for advancing therapeutic formulations in oncology research. -
Drug Intermediate
42-O-(2-Azidoethyl)-Rapamycin is an azide-modified derivative of Rapamycin, functioning as an important drug intermediate for synthetic applications. It facilitates the development of Rapamycin derivatives, which are of interest in various therapeutic contexts, particularly in cancer research and immunosuppression studies. This compound's unique structure allows for further modifications that can enhance biological activity and specificity in target engagement. -
Drug Intermediate
Methyl (3S,6R)-6-methyl-3-piperidinecarboxylate L-tartaric acid salt serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This compound plays a crucial role in the preparation of pharmaceutical agents, contributing to diverse chemical structures and medicinal properties. Its application is significant in the fields of medicinal chemistry and drug development. -
Drug Impurity
Sunitinib impurity 28 is a recognized impurity associated with Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor. It serves as a critical reference standard in the analysis of Sunitinib and is pivotal for assessing drug purity and stability in pharmaceutical formulations. This impurity is essential for quality control and research applications focused on the metabolism and pharmacokinetics of Sunitinib. -
Drug Impurity
Afatinib impurity 34 is a known impurity associated with the drug Afatinib, an irreversible ErbB receptor tyrosine kinase inhibitor. This compound is primarily utilized for quality control and analytical studies in pharmaceutical development to ensure the purity and compliance of Afatinib formulations. Its characterization is essential for understanding the potential impact of impurities on drug efficacy and safety profiles. -
Drug Intermediate
6,7-Dibromoquinoline-5,8-dione is a versatile drug intermediate utilized in the synthesis of a variety of biologically active compounds. This compound serves as a crucial building block in medicinal chemistry and pharmaceutical development, facilitating the creation of novel therapeutic agents. Its incorporation into chemical reactions can lead to the development of compounds with potential applications in diverse areas of drug discovery and development. -
Drug Impurity
Methyl 3-chlorobenzoate is a compound commonly categorized as a drug impurity. It is utilized in chemical research to study the implications of impurities in drug development processes. This reagent serves as a valuable tool for evaluating the stability and efficacy of pharmaceutical formulations. -
Drug Impurity
Rosuvastatin impurity 46, also known as Rosuvastatin ethyl ester, is a chemical impurity associated with the cholesterol-lowering drug Rosuvastatin. It is utilized primarily in drug development and quality control processes to assess the purity of Rosuvastatin formulations. This reagent aids researchers in understanding the metabolic pathways and potential impacts of drug impurities on pharmacokinetics and safety profiles. -
Drug Impurity
Rosuvastatin impurity 10, also known as 5-Oxo rosuvastatin, is a recognized impurity of Rosuvastatin. This compound serves as a reference standard in the assessment and quality control of Rosuvastatin formulations. Its characterization is essential for ensuring drug purity and compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Rivaroxaban impurity 47 is a chemical impurity associated with the anticoagulant Rivaroxaban, which directly targets factor Xa in the coagulation cascade. This compound serves as a crucial reference standard for quality control and stability testing in pharmaceutical research. Its characterization is essential for evaluating the purity of Rivaroxaban formulations during drug development and regulatory assessments. -
Drug Intermediate
Triphenylene is a highly symmetrical polycyclic aromatic hydrocarbon that serves as a valuable drug intermediate. It facilitates the synthesis of triphenyl polycyclic aromatic hydrocarbons (PAHs), which are significant in various chemical applications. Notably, Triphenylene demonstrates no carcinogenic activity in mouse skin application experiments, supporting its use in safe pharmaceutical development and research. -
Drug Intermediate
4-Methylbenzothioamide is a cyclic thioamide used as a building block in drug discovery chemistry. This compound serves as an important intermediate in the synthesis of various pharmaceutical agents. Its unique structure allows for the modification of bioactive molecules, facilitating the development of novel therapeutics. -
Impurity reference
Rabeprazole sulfone is a metabolite of the proton pump inhibitor Rabeprazole, serving as an impurity reference in pharmaceutical research. This compound is essential for quality control and analytical studies that require the assessment of Rabeprazole's purity. Its identification and quantification support the development of reliable therapeutic formulations and ensure compliance with regulatory standards. -
Drug Impurity
trans-4-[Bis(phenylmethyl)amino]cyclohexanecarboxylic acid functions primarily as a drug impurity. It is relevant in pharmaceutical research, particularly in the assessment of drug purity and the investigation of potential contaminants. This compound aids in understanding the implications of impurities in drug formulation and safety profiles. -
Drug Impurity
Dexamethasone impurity 3 is a known impurity of Dexamethasone, a synthetic glucocorticoid. This compound is relevant in pharmaceutical research and quality control, as it is necessary for assessing the purity and stability of Dexamethasone formulations. Understanding the presence and behavior of this impurity can facilitate the development of more effective and consistent glucocorticoid therapies. -
Drug Intermediate
N,N-Dimethyl-L-valine is a synthetic amino acid derivative commonly used as a drug intermediate in pharmaceutical synthesis. This compound serves as a valuable building block in the development of various bioactive molecules, facilitating the creation of novel therapeutic agents. Its structural properties contribute to the modulation of biological activity, making it an essential reagent in chemical research and drug discovery applications. -
Drug Intermediate
tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2) serves as a versatile drug intermediate, facilitating the synthesis of a range of bioactive molecules. This compound is particularly useful in the development of pharmaceuticals due to its ability to participate in multistep synthesis reactions, enhancing chemical pathways for novel drug discovery and development. Its unique structure enables precise functionalization, making it an essential reagent in chemical research and medicinal chemistry applications. -
Drug Impurity
Ticagrelor impurity 12 is identified as a chemical impurity associated with Ticagrelor, an antiplatelet medication. This compound is critical for analytical studies focusing on the purification and identification of drug metabolites. Its characterization is essential for ensuring the safety and efficacy of Ticagrelor in pharmaceutical research and quality control processes. -
Drug Impurity
Cinacalcet impurity 6 is a known impurity related to the active pharmaceutical ingredient Cinacalcet, which acts as a calcimimetic agent targeting the calcium-sensing receptor. This compound is utilized primarily in the assessment of drug purity and quality control in pharmaceutical development. Proper identification and quantification of this impurity are essential for ensuring the safety and efficacy of drug formulations containing Cinacalcet. -
Drug Impurity
Ticagrelor impurity 26 is a known impurity associated with the antiplatelet agent Ticagrelor, primarily targeting the P2Y12 receptor. This compound is crucial for the study of drug purity and quality control in pharmaceutical development. It aids researchers in understanding the implications of impurities on drug efficacy and safety, making it an essential tool for analytical and formulation studies in the pharmaceutical industry. -
Drug Impurity
Sildenafil impurity 17 is a defined impurity associated with the synthesis of Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor. This compound is important for assessing the purity of pharmaceutical formulations and plays a critical role in quality control during drug development. Researchers can utilize Sildenafil impurity 17 to ensure compliance with regulatory standards and investigate its impact on the efficacy and safety profiles of Sildenafil-based therapies. -
Drug Intermediate
2,2-Dibenzyl-1,3-propanediol serves as a crucial drug intermediate in the synthesis of various pharmacologically active compounds. It contributes to the formation of complex molecular structures, facilitating the development of new therapeutics. This compound is valuable in medicinal chemistry and drug development applications, where it supports the exploration of innovative treatments. -
Drug Intermediate
Methyl 9H-xanthene-9-carboxylate serves as a crucial intermediate in the synthesis of diverse active pharmaceutical compounds. This compound plays an essential role in the development of xanthene derivatives, which are of significant interest in chemical and medicinal research. Its utility in drug synthesis supports studies aimed at optimizing pharmacological properties and biological activities. -
Drug Intermediate
4-Chlorophenyl-2-pyridinylmethanol is a versatile synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound acts as a building block in the development of various bioactive molecules, facilitating the production of targeted therapeutics. Its efficacy in chemical reactions makes it a valuable reagent for researchers engaged in drug discovery and development. -
Drug Impurity
Anastrozole impurity 1 is a known impurity derived from the aromatase inhibitor Anastrozole, primarily targeting estrogen synthesis. This compound is critical for analytical chemistry and quality control in the pharmaceutical industry, serving as a reference standard for the identification and quantification of impurities in formulations containing Anastrozole. Researchers utilize it to ensure the purity and safety of drug products in compliance with regulatory standards. -
Drug Impurity
Ticagrelor impurity 7 is a known impurity associated with the antiplatelet agent Ticagrelor. This compound serves as a reference standard for the analysis and quality control of Ticagrelor in pharmaceutical formulations. Its identification is critical for ensuring the consistency and safety of Ticagrelor-based therapies in drug development and research applications. -
Drug Impurity
Rebamipide impurity 13 is a recognized impurity associated with Rebamipide, a drug primarily used for its gastroprotective properties. This compound serves as a valuable reference standard in the analysis and quality control of pharmaceutical formulations containing Rebamipide. Its presence may influence the pharmacological profile and therapeutic efficacy, making it essential for research applications focused on drug development and safety assessment.
